NIH Expanding Experimental Ebola Treatment Clinical Trial From Liberia Into Sierra Leone,…

Wall Street Journal: NIH Expands Testing of Ebola Drugs and Vaccines Into New Countries “…The NIH randomized controlled study of ZMapp has expanded from Liberia into Sierra Leone, where about 40 patients have been enrolled so far, according to H. Clifford Lane, deputy director of the NIH’s National Institute of Allergy and Infectious Diseases. He…More

Visit link:
NIH Expanding Experimental Ebola Treatment Clinical Trial From Liberia Into Sierra Leone,…